Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotechnology Innovation Organization
Biotech
New rules, higher stakes: Biopharma plays the long game in 2026
The industry has learned how the ball bounces—now it must decide where to play next.
Gabrielle Masson
Jan 26, 2026 2:40pm
'Why We Vaccinate': BIO targets lawmakers for immunization push
Oct 20, 2025 1:50pm
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
Jun 30, 2025 10:09am
100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 9:05am
BIO, Seaport, Orna and more—Chutes & Ladders
Apr 12, 2024 8:30am
BIO announces new CEO—Chutes & Ladders
Dec 8, 2023 9:30am
